Evidence-based management of hypertension
The treatment of hypertension is now evolving into a decision-making process of ever greater complexity. Not only has the range of drugs available increased but so too has our knowledge of the diversity of individual patients' responsiveness to therapy, and the need to tailor their treatment wi...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Harley, UK
tfm Publishing Limited
2010
|
| Edition: | First edition |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Call Number : | med WG 340 .W42 2010 |
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 101948 | ||
| 003 | MY-KLNDU | ||
| 005 | 20241220040124.0 | ||
| 008 | 221104 20102010xxka bi 001 0 eng d | ||
| 020 | |a 9781903378724 | ||
| 039 | 9 | |a 202211041155 |b VLOAD |c 201702131458 |d faezah |y 201611301204 |z hasniza | |
| 040 | |a UPNM |b eng |c UPNM |e rda | ||
| 060 | |a WG 340 | ||
| 090 | |a med WG 340 |b .W42 2010 | ||
| 100 | 1 | |a Weir, Matthew R.,d1952- | |
| 245 | 1 | 0 | |a Evidence-based management of hypertension |c Matthew R. Weir |
| 250 | |a First edition | ||
| 264 | 1 | |a Harley, UK |b tfm Publishing Limited |c 2010 | |
| 264 | 4 | |c © 2010 | |
| 300 | |a x, 232 pages |b illustrations |c 26 cm | ||
| 336 | |a text |2 rdacontent | ||
| 337 | |a unmediated |2 rdamedia | ||
| 338 | |a volume |2 rdacarrier | ||
| 504 | |a ncludes bibliographical references and index | ||
| 505 | 0 | |a Evidence-based management of hypertension: how much should you reduce blood pressure? / Jan N. Basile, Marvin Moser -- The effects of sodium and potassium intake on blood pressure / Sharon Turban, Lawrence J. Appel -- What is the optimal treatment in obesity-related hypertension? / Eric M. Brown, Matthew R. Weir -- Medical management of renal artery stenosis / John W. O'Bell, Lance D. Dworkin -- Optimal regimen-based pharmacotherapy of hypertension in patients with concomitant conditions / C. Venkata S. Ram -- The optimal management of patients with resistant hypertension due to aldosterone excess / Eduardo Pimenta, David A. Calhoun -- Should pre-hypertension be treated? / Joseph L. Izzo, Jr. -- What are optimal treatment goals for older patients with isolated systolic hypertension? / Raymond R. Townsend -- What is optimal treatment of hypertension in minority populations? / Radhika Kanthety, Jackson T. Wright Jr., Mahboob Rahman -- Treatment of hypertension in patients with ischemic heart disease / R. Michael Benitez -- Management of patients with left ventricular hypertrophy / Wallace R. Johnson, Jr. -- Management of hypertension in left ventricular systolic dysfunction / Faisal Siddiqi, Kristin Thanavaro, Mandeep R. Mehra -- Treatment of hypertension with cerebrovascular disease: what is the evidence? / William J. Elliott -- What is the optimal blood pressure treatment for patients with chronic kidney disease and/or albuminuria? / Rigas Kalaitzdis, George Bakris -- Hypertension management in diabetes / Deepashree Gupta [and others] | |
| 520 | |a The treatment of hypertension is now evolving into a decision-making process of ever greater complexity. Not only has the range of drugs available increased but so too has our knowledge of the diversity of individual patients' responsiveness to therapy, and the need to tailor their treatment with reference to a wide variety of additional factors. In order to provide effective patient care, the clinician needs to be aware of all the options available, but also of the evidence supporting their use and the extent to which that evidence justifies the choices made. In this volume, leading authorities in their fields draw on the available evidence to provide answers to a series of key clinical questions facing the clinician treating hypertension. The book provides answers to these and many other questions, as the authors present an expert analysis of the available evidence and offer authoritative recommendations for treatment planning. In each chapter, tables highlight evidence from a variety of sources, and every chapter concludes with a series of key practice points that present a summary of evidence-based recommendations for best practice, graded according to the quality of that evidence | ||
| 592 | |a 00010377/16 |b 30/12/2016 |c RM 253.05 |h Areesh | ||
| 650 | 0 | |a Hypertension |x Treatment | |
| 650 | 1 | 2 | |a Evidence-Based Medicine |
| 650 | 2 | 2 | |a Hypertension |x therapy |
| 999 | |a vtls000057789 |c 101948 |d 101948 | ||